Get Connected:

ENDO 2013 is “the largest endocrinology meeting that serves as the premier event to showcase the best of endocrinology scientific innovations and research. It’s also an excellent venue to expand your knowledge and network with peers and world-renowned experts.”
ENDO 2013

ENDO 2013 | ENDO 2013

Conference Coverages

Acute Hypertriglyceridemia, Insulin Resistance, and Platelet Hyperactivity in PCOS
Acute Hypertriglyceridemia, Insulin Resistance, and Platelet Hyperactivity in PCOS
Hypertriglyceridemia combined with insulin resistance may lead to increased platelet activation in women with polycystic ovary syndrome (PCOS).
Improved Insulin Sensitivity in Men after 'Catch-Up' Sleep
Insulin sensitivity improved after three nights of adequate sleep in nondiabetic men after days of inadequate sleep.
Tight Glycemic Control and Improved Mortality in ICU Patients
Study results suggest that tight glycemic control is associated with decreased length of stay and improved mortality.
Lower Rate of Hypoglycemia with Insulin Degludec in Obese, Diabetic Patients
Results of a recent meta-analysis suggest lower rates of hypoglycemia with insulin degludec in obese patients when compared with insulin glargine.
Vitamin D Supplementation Does Not Affect Obesity-Related CV Risk Factors
Study shows that 12 weeks of vitamin D supplementation in obese adolescents does not affect cardiometabolic risk factors.
Update on the Endocrine Society Practice Guidelines for Evaluation and Treatment of Hypertriglyceridemia
At ENDO 2013, an expert panel discussed the consensus statement on the evaluation and treatment of hypertriglyceridemia and the evidence supporting the recommendations.
Beneficial Effects of Growth Hormone on Body Composition and CV Risk Factors in Obese Men
Study results show improvements in body composition, intrahepatic lipids, and cardiovascular risk markers in obese men treated with growth hormone for six months compared with placebo.

Most Popular

$vacMongoViewPlus$ $vAR$